MRPL24 Drives Breast Cancer Metastasis and Stemness by Targeting C-MYC, BRD4, and STAT3

Overview

Journal 3 Biotech

Publisher Springer

Date 2025 Jan 13

PMID 39802327

Authors

Abdul Jamil Khan

Islam Uddin Khan

Shad Man

Shihao Liu

Gaowa Ailun

Manzar Abbas

Feng Zhang

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-024-04196-z.

References

Khan A, Man S, Abbas M, Liu S, Zhang F . FBXO8 is a novel prognostic biomarker in different molecular subtypes of breast cancer and suppresses breast cancer progression by targeting c-MYC. Biochim Biophys Acta Gen Subj. 2024; 1868(4):130577. DOI: 10.1016/j.bbagen.2024.130577. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Cai M, Li H, Chen R, Zhou X . MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway. Cancer Manag Res. 2021; 13:2009-2024. PMC: 7920513. DOI: 10.2147/CMAR.S296038. View

Thul P, Lindskog C . The human protein atlas: A spatial map of the human proteome. Protein Sci. 2017; 27(1):233-244. PMC: 5734309. DOI: 10.1002/pro.3307. View

Zhang H, Li Z, Dai Z, Wang J, Li L, Zong Q . Interaction of MRPL9 and GGCT Promotes Cell Proliferation and Migration by Activating the MAPK/ERK Pathway in Papillary Thyroid Cancer. Int J Mol Sci. 2022; 23(19). PMC: 9570013. DOI: 10.3390/ijms231911989. View

Shi X, Yang Y, Ma X, Zhou Y, Guo Z, Wang C . Probabilistic cell/domain-type assignment of spatial transcriptomics data with SpatialAnno. Nucleic Acids Res. 2023; 51(22):e115. PMC: 10711557. DOI: 10.1093/nar/gkad1023. View

Li X, Guo J, Lian J, Gao F, Khan A, Wang T . Molecular Simulation Study on the Interaction between Tyrosinase and Flavonoids from . ACS Omega. 2021; 6(33):21579-21585. PMC: 8388101. DOI: 10.1021/acsomega.1c02593. View

Dushyanthen S, Beavis P, Savas P, Teo Z, Zhou C, Mansour M . Relevance of tumor-infiltrating lymphocytes in breast cancer. BMC Med. 2015; 13:202. PMC: 4547422. DOI: 10.1186/s12916-015-0431-3. View

Anders L, Ke N, Hydbring P, Choi Y, Widlund H, Chick J . A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell. 2011; 20(5):620-34. PMC: 3237683. DOI: 10.1016/j.ccr.2011.10.001. View

Durrant J, McCammon J . Molecular dynamics simulations and drug discovery. BMC Biol. 2011; 9:71. PMC: 3203851. DOI: 10.1186/1741-7007-9-71. View

10.

Chandrashekar D, Karthikeyan S, Korla P, Patel H, Shovon A, Athar M . UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022; 25:18-27. PMC: 8788199. DOI: 10.1016/j.neo.2022.01.001. View

11.

Dhanasekaran R, Deutzmann A, Mahauad-Fernandez W, Hansen A, Gouw A, Felsher D . The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2021; 19(1):23-36. PMC: 9083341. DOI: 10.1038/s41571-021-00549-2. View

12.

Heap G, Trynka G, Jansen R, Bruinenberg M, Swertz M, Dinesen L . Complex nature of SNP genotype effects on gene expression in primary human leucocytes. BMC Med Genomics. 2009; 2:1. PMC: 2628677. DOI: 10.1186/1755-8794-2-1. View

12.

Brummel K, Eerkens A, de Bruyn M, Nijman H . Tumour-infiltrating lymphocytes: from prognosis to treatment selection. Br J Cancer. 2022; 128(3):451-458. PMC: 9938191. DOI: 10.1038/s41416-022-02119-4. View

13.

Jezequel P, Campone M, Gouraud W, Guerin-Charbonnel C, Leux C, Ricolleau G . bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer. Breast Cancer Res Treat. 2011; 131(3):765-75. DOI: 10.1007/s10549-011-1457-7. View

14.

Gao F, Li X, Xu K, Wang R, Guan X . c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment. Cell Commun Signal. 2023; 21(1):28. PMC: 9887805. DOI: 10.1186/s12964-023-01043-1. View

15.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

16.

Zhuang L, Meng Z, Yang Z . MRPL27 contributes to unfavorable overall survival and disease-free survival from cholangiocarcinoma patients. Int J Med Sci. 2021; 18(4):936-943. PMC: 7807179. DOI: 10.7150/ijms.50782. View

17.

Tang B, Zhu J, Zhao Z, Lu C, Liu S, Fang S . Diagnosis and prognosis models for hepatocellular carcinoma patient's management based on tumor mutation burden. J Adv Res. 2021; 33:153-165. PMC: 8463909. DOI: 10.1016/j.jare.2021.01.018. View

18.

Hospital A, Goni J, Orozco M, Gelpi J . Molecular dynamics simulations: advances and applications. Adv Appl Bioinform Chem. 2015; 8:37-47. PMC: 4655909. DOI: 10.2147/AABC.S70333. View